ADIPOQ and metabolic dysfunction-associated steatohepatitis: A combined diagnostic panel combining adiponectin, visfatin, TNF-α, and IL-6 could effectively differentiate NASH and SS with a SEN of 90% and SPE of 66%[74], suggesting the possible usage as an early screening model for NASH.